(717) 737-6470

MEDRAD (now Bayer HealthCare Radiology & Interventional)

For more than 40 years, MEDRAD has been committed to improving patient outcomes by developing, marketing, and servicing innovative, cost-efficient devices for diagnosing and treating diseases. Sold worldwide to hospitals and medical imaging centers, MEDRAD’s products include fluid injection systems for radiology and cardiology, endovascular devices for the treatment of cardiovascular disease, and equipment for visualization procedures such as computed  tomography and magnetic resonance imaging. MEDRAD is a business of Bayer HealthCare.
This is the second Baldrige Award for MEDRAD. The company also was honored as a recipient in 2003.
MEDRAD’s global headquarters are in Warrendale, Pennsylvania, with other U.S. offices in Indianola, Pennsylvania; Pittsburgh,  Pennsylvania; Saxonburg, Pennsylvania; and Minneapolis, Minnesota. MEDRAD’s international headquarters are in the Netherlands and Australia, supporting field sales and service centers in Brazil, Canada, China, Colombia, Denmark, Cyprus, France, Germany, Italy, Japan, Mexico, Norway, Singapore, Sweden, and the United Kingdom.
Revenues for the company were approximately $625 million in 2009. MEDRAD has a workforce of more than 2,000 persons.